0
     

Report Added
Report already added
UAE Patient At Home Testing Kits Market, By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine Testing, Others), By Sample (Blood, Urine, Saliva/Swab, Others), By Usage (Reusable v/s Disposable), By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce), By Region, Competition Forecast & Opportunities, 2027

UAE Patient At Home Testing Kits Market, By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine Testing, Others), By Sample (Blood, Urine, Saliva/Swab, Others), By Usage (Reusable v/s Disposable), By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce), By Region, Competition Forecast & Opportunities, 2027

The UAE patient at home testing kits market is projected to grow at a formidable CAGR during the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of chronic disorders and increasing health consciousness among the population. Besides, the advent of innovative solutions to improve the accuracy and reduce the testing time coupled with the growing investments by market players for R&D are expected to contribute to the growth of the UAE patient at home testing kits market.
The International Diabetes Federation (IDF) projects that about 300 million persons worldwide will have Diabetes Mellitus (DM) by 2025. Diabetes is a multifactorial disease caused by genetic or environmental factors, which is characterized by elevated glucose levels, or hyperglycemia. Diabetes is a risk factor for many cardiovascular conditions, including angina, myocardial infarction, and stroke. Adoption of a sedentary lifestyle and unhealthy eating habits is fueling the occurrence of diabetes among people. As consumers are increasingly becoming aware of the symptoms of diabetes, they are widely adopting the patient at-home testing kits that show results in a short duration. Moreover, market players are introducing affordable, accurate patient at-home testing kits and creating lucrative marketing strategies to attract customers, which is supporting the market growth.
Customers have started to purchase through the online sales channel due to widespread smart device adoption and strong internet penetration. Customers find online pharmacies very convenient because they offer speedy doorstep delivery and generous discounts on patient at-home testing kits. An increase in the number of market participants providing products and their attempts to make stock and supply chains are expected to contribute to the growth of the UAE patient at-home testing kits market.
The UAE patient at home testing kits market is segmented on the basis of test type, sample, usage, distribution channel, regional distribution, and company. Based on test type, the market is divided into blood glucose testing, pregnancy & fertility testing, cholesterol testing, COVID-19 testing, urine testing, and others. The blood glucose testing segment is anticipated to dominate the UAE patient at home testing kits market, owing to the increasing efforts by consumers to stay fit and the high availability of accurate blood glucose testing kits available in the market.
Major players operating in the UAE patient at-home testing kits market are Abbott Laboratories, SA (UAE), Roche Diagnostics Middle East FZCO, Siemens Healthineers UAE, Quidel Corporation, GE Healthcare UAE, Procter & Gamble Middle East FZE, Swiss Precision Diagnostics GmbH (Clearblue), First Response, among others.

Years considered for this report:

Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023–2027

Objective of the Study:
•To analyze the historical growth in the market size of the UAE patient at home testing kits from 2017 to 2021.
•To estimate and forecast the market size of UAE patient at home testing kits market from 2023 to 2027 and growth rate until 2027.
•To classify and forecast the UAE patient at home testing kits market based on test type, sample, usage, distribution channel, region, and company.
•To identify the dominant region or segment in the UAE patient at home testing kits market.
•To identify drivers and challenges for the UAE patient at home testing kits market.
•To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the UAE patient at home testing kits market.
•To identify and analyze the profiles of leading players operating in the UAE patient at home testing kits market.
•To identify key sustainable strategies adopted by market players in UAE patient at home testing kits market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of the UAE patient at home testing kits market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
•Market research and consulting firms
•Government bodies such as regulating authorities and policy makers
•Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:
In this report, UAE patient at home testing kits market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•UAE Patient At Home Testing Kits Market, By Test Type:
oBlood Glucose Testing
oPregnancy & Fertility Testing
oCholesterol Testing
oCOVID-19 Testing
oUrine Testing
oOthers
•UAE Patient At Home Testing Kits Market, By Sample:
oBlood
oUrine
oSaliva/Swab
oOthers
•UAE Patient At Home Testing Kits Market, By Usage:
oReusable
oDisposable
•UAE Patient At Home Testing Kits Market, By Distribution Channel:
oRetail Pharmacy Stores
oHypermarket/Supermarket
oE-Commerce
•UAE Patient At Home Testing Kits Market, By Region:
oDubai
oAbu Dhabi
oSharjah
oRest of UAE
Competitive Landscape

Company Profiles:Detailed analysis of the major companies present in UAE patient at home testing kits market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Contents

1.Product Overview
2.Research Methodology
3.Impact of COVID-19 on UAE Patient At Home Testing Kits Market
4.Executive Summary
5.Voice of Customers
6.UAE Patient At Home Testing Kits Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine Testing, Others)
6.2.2.By Sample (Blood, Urine, Saliva/Swab, Others)
6.2.3.By Usage (Reusable v/s Disposable)
6.2.4.By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce)
6.2.5.By Region
6.2.6.By Company (2021)
6.3.Product Market Map
7.UAE Reusable Patient At Home Testing Kits Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Test Type
7.2.2.By Sample
7.2.3.By Distribution Channel
8.UAE Disposable Patient At Home Testing Kits Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Test Type
8.2.2.By Sample
8.2.3.By Distribution Channel
9.Market Dynamics
9.1.Drivers
9.2.Challenges
10.Market Trends & Developments
11.Policy & Regulatory Landscape
12.UAE Economic Profile
13.Competitive Landscape
13.1.Competition Outlook
13.2.Company Profiles
13.2.1.Abbott Laboratories, SA (UAE)
13.2.2.Roche Diagnostics Middle East FZCO
13.2.3.Siemens Healthineers UAE
13.2.4.Quidel Corporation
13.2.5.GE Healthcare UAE
13.2.6.Procter & Gamble Middle East FZE
13.2.7.Swiss Precision Diagnostics GmbH (Clearblue)
13.2.8.First Response
14.Strategic Recommendations

Report Title: UAE Patient At Home Testing Kits Market, By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine Testing, Others), By Sample (Blood, Urine, Saliva/Swab, Others), By Usage (Reusable v/s Disposable), By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce), By Region, Competition Forecast & Opportunities, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM